CAS: 369358-07-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | A 357300 REF: 3D-UPA35807CAS: 369358-07-6 | Min. 95% | To inquire | Fri 27 Dec 24 |
 | A-357300 REF: TM-T69346CAS: 369358-07-6 | - - - | 1,796.00 €~3,100.00 € | Wed 15 Jan 25 |
A 357300
CAS:369358-07-6
A 357300 is a novel drug that has been shown to be effective in treating …
Formula:
C15H22ClN3O3S
Purity:
Min. 95%
Molecular weight:
359.9 g/mol
Ref: 3D-UPA35807
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
A-357300
CAS:369358-07-6
A-357300: potent reversible MetAP2 inhibitor, IC50=0.12 uM; promising for neuroblastoma treatment.
Formula:
C15H22ClN3O3S
Color and Shape:
Solid
Molecular weight:
359.87
Ref: TM-T69346
| 25mg | 1,796.00 € | ||
| 50mg | 2,352.00 € | ||
| 100mg | 3,100.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
